Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and internationally. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the...
22 insider purchases on record · latest filing 2026-05-11.
Insiders have also filed 679 sale transactions at ATRA.